SCHEMBL27630786

SCHEMBL27630786

FC(F)(F)c1nc(NC2CC2)c2ncn(-c3ccnc(Nc4ccncc4)n3)c2n1

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 6/20 0.44
ULK1 O75385 6/20 0.42
KDR P35968 1/20 0.39
MKNK2 Q9HBH9 5/20 0.39
ULK2 Q8IYT8 2/20 0.39
ADORA3 P0DMS8 2/20 0.39
ADORA2A P29274 2/20 0.39
ADORA1 P30542 2/20 0.39
FLT3 P36888 1/20 0.37
TYRO3 Q06418 1/20 0.37
MERTK Q12866 1/20 0.37
GAS6 Q14393 1/20 0.37
MALT1 Q9UDY8 2/20 0.37
TLR7 Q9NYK1 1/20 0.36
PTK2 Q05397 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3131784 0.89 MKNK1 (0.46) MKNK1MKNK2MALT1TLR7
SCHEMBL3130704 0.86 PDE4A (0.45) MKNK1MKNK2ADORA3ADORA2AADORA1
SCHEMBL3131813 0.85 MKNK1 (0.39) MKNK1MKNK2ADORA3ADORA2AADORA1
SCHEMBL6276985 0.84 KDR (0.46) MKNK1ULK1KDRMKNK2ADORA3
SCHEMBL3137469 0.82 PDE4A (0.50) MKNK1MKNK2MALT1
SCHEMBL3137715 0.82 PDE4A (0.41) MALT1TLR7
SCHEMBL3141393 0.82 TLR7 (0.43) ULK1MALT1TLR7
SCHEMBL3128339 0.81 PDE4A (0.40) MKNK1MKNK2ADORA3ADORA2AADORA1
SCHEMBL3145980 0.81 PDE4A (0.40) MKNK1MKNK2ADORA3ADORA2AMALT1
SCHEMBL3141374 0.80 PDE4A (0.39) MKNK1MKNK2MALT1TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1688580-A 2-Trifluoromethyl-6-aminopurine derivatives as phosphodiesterase 4 inhibitors MEMORY PHARM CORP (US) 2005-10-26 CN claimed
CN-1688580-A 2-Trifluoromethyl-6-aminopurine derivatives as phosphodiesterase 4 inhibitors MEMORY PHARM CORP (US) 2005-10-26 CN disclosed